Introduction
The deletion of long arm of chromosome 5 (del (5) (q32)) is a very rare event in Acute Lymphoblastic Leukemia (ALL) and has not been analyzed extensively.
The del (5)(q) is associated with 20-30% of MDS, either as the sole identifiable abnormality, or in combination with one or more additional abnormalities. [1] [2] [3] [4] Although, this particular abnormality is common to myeloid lineage associated neoplasias, nevertheless, we present a case of T-ALL with del(5)(q32) as a sole chromosomal abnormality with case history and discussed with relevant literature.
A 75-year-old male patient presented to the OPD Del(5)(q) is a common chromosomal abnormality with favourable prognosis in Myelodysplastic Syndrome (MDS) and Acute myeloid leukemia (AML). However, del(5)(q) is also seen rarely in Acute lymphoblastic leukemia (ALL) and its significance remains poorly understood. We present here, a case report of diagnosis of an adult 75 year old patient of ALL with a cytogenetic abnormality of del(5)(q32).
His clinical features, morphology and immunophenotyping findings were suggestive of T-ALL. Relevant literature has been reviewed and discussed.
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Materials and Methods
The bone marrow aspirate was cultured for direct and 24hrs in RPMI-1640 medium supplemented with 20%
qualified; heat inactivated fetal bovine serum, 100 U/ml
Penicillin and streptomycin, without any mitogen at [5]
Results
All 25 metaphases consistently showed a karyotype of 46, XY, del(5)(q32) [ Figure 1 ].
Discussion
Del (5)(q32) is a most frequent and documented recurrent chromosome abnormality with favourable prognosis in MDS. [1, 3, 4, [6] [7] [8] This is also reported in acute myeloid leukemia (AML) transformed from MDS (1).
The rarity of (5)(q) deletion in ALL and the same abnormality in our patient persuaded us to explore the literature. Del(5)(q) is uncommonly observed in ALL. Until now, nearly 20 cases of ALL with del (5) (q) has been reported in literature. In contrast to its presence in AML, del(5) (q) in ALL is not an adverse prognostic indicator, and it appears to be more frequent in children. [10] Our patient is an adult and has been diagnosed as having T-ALL by flow cytometry and ALL-L2 by morphology. The patient is undergoing treatment and will be followed up to evaluate the prognostic significance of del (5) changes. This abnormality is not only reported in leukemia but also reported in small cell neuroendocrine lung carcinoma. [12] The break point may vary from ALL to MDS to CLL to lung carcinoma. These are difficult to estimate by conventional cytogenetic analysis, because small differences in base pairs at deletions are beyond the sensitivity of the technique. Further studies are required to elucidate the prognostic value of del(5)(q) in more ALL patients and to identify candidate genes that may play a vital role in the pathogenesis of ALL. 
